Carregant...
Targeting the Mammalian Target of Rapamycin in Lung Cancer
Lung cancer is the leading cause of cancer death worldwide. Despite advances in its prevention and management, the prognosis of patients with lung cancer remains poor. Therefore, much attention is being given to factors that contribute to the development of this disease, the mechanisms that drive on...
Guardat en:
| Publicat a: | Am J Med Sci |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5384343/ https://ncbi.nlm.nih.gov/pubmed/27865299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjms.2016.08.014 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|